Form D · Other

Morphlabs, Inc.

Manhattan Beach, CA · CIK 0001593165

Offering snapshot reported Dec 2, 2013 · SEC filing

Reported sold
$8.45M
Offering amount: $10.9M
Investors reported
41
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 28, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 2, 2013Initial$8,449,862No comparison41SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-207257

Source: Form D, filed Dec 2, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Victor Alvarez Director
Rey Banatao Director, Executive
Dado Banatao Director
Martin Bautista Director
Kevin Belmonte Director
Winston Damarillo Director
Mike Gleason Executive

Issuer details

Industry: Other (See others in industry)

Address:
3601 Aviation Blvd., Suite 1000
Manhattan Beach, CA, 90266